Purchase Order 75N95024P00499
Award Date 8/26/24
Potential Completion Date 12/2/24
Potential Value $113K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm-fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the National Institutes of Health (NIH), to Psomagen Inc., a for-profit organization and manufacturer of goods. The $23,030 contract is for OLINK HT ANALYSIS services, which likely refers to genomic sequencing and analysis capabilities provided by Psomagen. The contract has an ultimate completion date of July 29, 2025 and was awarded on July 30, 2024...
- This federal contract award, valued at $11,844.00, was issued by the National Institute of Neurological Disorders and Stroke (NINDS) to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract is for the proteomic analysis of cerebrospinal fluid (CSF) samples from patients with amyotrophic lateral sclerosis (ALS) due to mutations in the CHCHD10 gene, using Olink's Explore HT technology. This purchase order-type contract has a firm fixed price and an ultimate completion...
- This is a $3,849,800.00 firm fixed-price purchase order contract awarded to Psomagen Inc., a small business, by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH). The contract is for neurodegenerative disease research, including whole genome sequencing services, with a completion date of September 14, 2024. Psomagen Inc. is a subsidiary of Macrogen, Inc. and is a provider of genomic sequencing, bioinformatics, and related services to federal government...
- This $24,940 firm-fixed-price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency, to Psomagen Inc., a for-profit manufacturer of genomic and molecular biology services. The contract is to provide the Olink Explore HT platform to support the Sickle Cell Branch's efforts to detect proteomic biomarkers in individuals with sickle cell disease. The award does not have a set-aside designation. Psomagen has previously received other federal contract awards...
- This is a federal purchase order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a genomics and molecular biology services company. The contract, valued at $15,344.80, is for Psomagen to provide OLINK EXPLORE HT (partial panel use) services to support next-generation sequencing-based proteomics analysis of plasma samples from hospitalized sepsis patients. The contract is not associated...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The $30,000 firm fixed-price purchase order was not set aside for any specific business type. Under this contract, Psomagen will provide a range of genomic and molecular biology services to support research across various NIH institutes, including the National Institute on Aging,...
- This is a $24,000 firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Psomagen Inc., a for-profit genomics services company. The contract is for providing ongoing Olink proteomics analysis for Batch 2 of sickle cell disease patient samples as part of the NHLBI's Laboratory of Sickle Cell Genetics and Pathophysiology research program. The award is not set aside and has an ultimate...
- This is a federal purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to Psomagen Inc., a subsidiary of Macrogen, Inc. The contract, valued at $4,942.00, is for DNA sequencing services. It is not a set-aside contract. The contract supports NIAID's research efforts, potentially including work on neurodegenerative diseases, cancer, and infectious diseases. Psomagen has previously received...
- This is a firm fixed-price purchase order awarded by the National Institute of Mental Health (NIMH), a civilian agency, to Psomagen Inc., a genomics and molecular biology services company based in Rockville, Maryland. The $180,000 contract has a period of performance ending on May 19, 2025. Psomagen Inc. is a subsidiary of the parent company Macrogen, Inc., which is a leading provider of genomic sequencing and bioinformatics services to the U.S. federal government. The contract does not have a...
- This is a $24,940 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Psomagen Inc., a for-profit manufacturer and genomics/molecular biology services company, for Olink proteomic assays to support the Laboratory of Sickle Cell Genetics and Pathophysiology's research on the relationship between the TTR V122I genetic mutation and its protein variant. The award is not associated with a set-aside program and has an ultimate...